Elanco Animal Health Beats Q2 Earnings Estimates but Faces Increasing Headwinds
Elanco Animal Health (NYSE: ELAN) didn't have much exciting news when the company reported its first-quarter results in May. Revenue was down 1% and adjusted earnings had dropped 23%.
But there was some better news -- and some bad news -- when Elanco announced its second-quarter results before the market opened on Tuesday. Here are the highlights from the animal health company's Q2 update.
Image source: Getty Images.
Source Fool.com
